Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cure Stone
- Development stage
- Unknown
- Lead developer
- Ritz Pharma
- Administration
- Oral
01
Overview
Cure Stone is an Ayurvedic herbal formulation developed and marketed by Ritz Pharma. It is primarily indicated for the management of kidney stones (renal calculi) and urinary tract infections (UTIs). As a traditional medicine, it is formulated to exert lithontriptic (stone-dissolving) and diuretic effects, facilitating the natural disintegration and passage of stones through the urinary tract. The product is administered orally in tablet form and is designed to provide symptomatic relief from the pain and inflammation associated with urolithiasis and urinary disorders.
- Brand names
- Cure Stone
- Other names
- Cure Stone Tab.
Beyond the preview
Go deeper on Cure Stone.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cure Stone.